Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemieTek is a premier provider of high-quality small molecule inhibitors, chemical probes, and reference compounds for the global life sciences research community. The company specializes in the custom synthesis and bulk manufacture of complex organic molecules, including kinase inhibitors, GPCR ligands, and epigenetic modulators. ChemieTek serves a diverse clientele ranging from academic laboratories to major pharmaceutical and biotechnology companies, ensuring high purity and analytical validation for all products. Their catalog features a wide array of bioactive compounds used in oncology, neurology, and metabolic disease research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChemieTek.